Page 46 - 《南京医科大学学报（自然科学版）》2026年第3期
P. 46
第46卷第3期
·354 · 南 京 医 科 大 学 学 报 2026年3月
cell sequencing technology and its applications in triple⁃ proved machine learning ⁃ based predictive models for
negative breast cancer［J］. Breast Cancer（Dove Med breast cancer diagnosis［J］. Int J Environ Res Public
Press），2022，14：465-474 Health，2022，19（6）：3211
［51］XU K，WANG R T，XIE H，et al. Single ⁃ cell RNA se⁃ ［60］XUE W W，YU Y，YAO Y Z，et al. Breast cancer cells
quencing reveals cell heterogeneity and transcriptome pro⁃ have an increased ferroptosis risk induced by system x c ⁃
file of breast cancer lymph node metastasis［J］. Oncogene⁃ blockade after deliberately downregulating CYTL1 to me⁃
sis，2021，10（10）：66 diate malignancy［J］. Redox Biol，2024，70：103034
［52］ZHAO P，WANG S，JIANG J，et al. Targeting lactate me⁃ ［61］SINGH A，DASHNYAM M，CHIM B，et al. Anxiolytic
tabolism and immune interaction in breast tumor via pro⁃ drug FGIN⁃1⁃27 ameliorates autoimmunity by metabolic
tease⁃triggered delivery［J］. J Control Release，2023，358： reprogramming of pathogenic Th17 cells［J］. Sci Rep，
706-717 2020，10（1）：3766
［53］ZHANG A，FAN T，LIU Y，et al. Regulatory T cells in im⁃ ［62］LENGAUER F，GEISSLINGER F，GABRIEL A，et al. A
mune checkpoint blockade antitumor therapy［J］. Mol metabolic shift toward glycolysis enables cancer cells to
Cancer，2024，23（1）：251 maintain survival upon concomitant glutamine depriva⁃
［54］TENG Y J，XU L C，LI W J，et al. Targeting reactive oxy⁃ tion and V⁃ATPase inhibition［J］. Front Nutr，2023，10：
gen species and fat acid oxidation for the modulation of 1124678
tumor ⁃ associated macrophages：a narrative review［J］. ［63］JIANG W，JIANG Y，ZHANG X H，et al. Metabolomic
Front Immunol，2023，14：1224443 analysis reveals the influence of HMBOX1 on RAW264.7
［55］SONG Y F，ZHU X J，LIN Z，et al. The potential value of cells proliferation based on UPLC⁃MS/MS［J］. BMC Ge⁃
serum chemerin in patients with breast cancer［J］. Sci nomics，2023，24（1）：272
Rep，2021，11（1）：6564 ［64］WAN W J，AO X，CHEN Q，et al. METTL3/IGF2BP3 axis
6
［56］CHANG X，XING P. Identification of a novel lipid metabo⁃ inhibits tumor immune surveillance by upregulating N ⁃
lism ⁃ related gene signature within the tumour immune methyladenosine modification of PD⁃L1 mRNA in breast
microenvironment for breast cancer［J］. Lipids Health cancer［J］. Mol Cancer，2022，21（1）：60
Dis，2022，21（1）：43 ［65］卢蓉蓉，瞿 菲，李 薇. 抗体偶联药物用于乳腺癌治
［57］ADDANKI S，MEAS S，SARLI V N，et al. Applications of 疗的耐药机制研究进展［J］. 南京医科大学学报（自然
circulating tumor cells and circulating tumor DNA in pre⁃ 科学版），2025，45（5）：707-717
cision oncology for breast cancers［J］. Int J Mol Sci，2022， LU R R，QU F，LI W. Research progress on drug resis⁃
23（14）：7843 tance mechanism of antibody coupled drugs in the treat⁃
［58］KHELLA C A，MEHTA G A，MEHTA R N，et al. Recent ment of breast cancer［J］. Journal of Nanjing Medical Uni⁃
advances in integrative multi ⁃ omics research in breast versity（Natural Sciences），2025，45（5）：707-717
and ovarian cancer［J］. J Pers Med，2021，11（2）：149 （收稿：2025-05-19；修回：2025-06-19；录用：2025-07-04）
［59］RASOOL A，BUNTERNGCHIT C，TIEJIAN L，et al. Im⁃ （本文编辑：陈汐敏）
